These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 19519462

  • 1. Retinoids as critical modulators of immune functions: new therapeutic perspectives for old compounds.
    Montrone M, Martorelli D, Rosato A, Dolcetti R.
    Endocr Metab Immune Disord Drug Targets; 2009 Jun; 9(2):113-31. PubMed ID: 19519462
    [Abstract] [Full Text] [Related]

  • 2. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
    Uray IP, Dmitrovsky E, Brown PH.
    Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
    [Abstract] [Full Text] [Related]

  • 3. [Retinoid signalling pathways].
    Fukasawa H, Shudo K.
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [Abstract] [Full Text] [Related]

  • 4. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
    Lømo J, Smeland EB, Ulven S, Natarajan V, Blomhoff R, Gandhi U, Dawson MI, Blomhoff HK.
    J Cell Physiol; 1998 Apr; 175(1):68-77. PubMed ID: 9491782
    [Abstract] [Full Text] [Related]

  • 5. Retinoids regulate stem cell differentiation.
    Gudas LJ, Wagner JA.
    J Cell Physiol; 2011 Feb; 226(2):322-30. PubMed ID: 20836077
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinoids selective for retinoid X receptor response pathways.
    Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI, Pfahl M.
    Science; 1992 Dec 18; 258(5090):1944-6. PubMed ID: 1335166
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Retinoids in cancer therapy.
    Smith MA, Parkinson DR, Cheson BD, Friedman MA.
    J Clin Oncol; 1992 May 18; 10(5):839-64. PubMed ID: 1569455
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M, Guidez F, Delva L, Agadir A, Degos L, Chomienne C.
    Bull Cancer; 1992 May 18; 79(7):697-704. PubMed ID: 1334741
    [Abstract] [Full Text] [Related]

  • 15. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM, Offterdinger M, Huber H, Grunt TW.
    Cancer Res; 2000 Oct 01; 60(19):5479-87. PubMed ID: 11034091
    [Abstract] [Full Text] [Related]

  • 16. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors.
    LeMotte PK, Keidel S, Apfel CM.
    Biochim Biophys Acta; 1996 Mar 15; 1289(2):298-304. PubMed ID: 8600988
    [Abstract] [Full Text] [Related]

  • 17. Nuclear retinoid receptors and the transcription of retinoid-target genes.
    Bastien J, Rochette-Egly C.
    Gene; 2004 Mar 17; 328():1-16. PubMed ID: 15019979
    [Abstract] [Full Text] [Related]

  • 18. Retinoids in cancer therapy and chemoprevention: promise meets resistance.
    Freemantle SJ, Spinella MJ, Dmitrovsky E.
    Oncogene; 2003 Oct 20; 22(47):7305-15. PubMed ID: 14576840
    [Abstract] [Full Text] [Related]

  • 19. Retinoic acid receptors: from molecular mechanisms to cancer therapy.
    di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette-Egly C, Lo-Coco F, Ascenzi P, Nervi C.
    Mol Aspects Med; 2015 Feb 20; 41():1-115. PubMed ID: 25543955
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.